云南白药

- 000538

-

-  -

-
昨收盘:- 今开盘:- 最高价:- 最低价:-
市值:-亿元 流通:- 成交:-手 换手:-
历年数据:  2025  2024  2023  2022  2021  2020  2019  2018  2017  2016 
云南白药(000538) 利润表
单位:万元
报表日期2025-09-302025-06-302025-03-312024-12-312024-09-30
一、营业总收入3,065,421.422,125,710.291,084,123.774,003,330.082,991,515.51
营业收入3,065,421.422,125,710.291,084,123.774,003,330.082,991,515.51
二、营业总成本2,607,476.091,783,628.62875,117.193,520,679.732,548,075.38
营业成本2,143,958.981,469,786.81742,033.532,886,476.622,141,884.69
营业税金及附加16,862.8312,577.375,338.5324,311.7416,805.45
销售费用371,529.98251,637.19107,013.24487,950.20330,647.60
管理费用55,527.4936,347.9015,640.11103,755.3549,957.61
财务费用-3,903.01-2,310.66-920.44-15,555.51-12,838.24
研发费用23,499.8215,590.016,012.2233,741.3321,618.26
资产减值损失----------
公允价值变动收益8,176.047,003.754,096.4613,683.70-1,877.41
投资收益95,117.1283,962.8722,255.6377,693.7568,514.32
其中:对联营企业和合营企业的投资收益89,437.8578,353.0323,324.8177,427.9570,090.78
汇兑收益----------
三、营业利润560,505.28422,031.63225,530.55571,162.18501,088.91
加:营业外收入1,858.801,752.54503.841,548.331,169.93
减:营业外支出854.23596.99436.244,238.55933.71
其中:非流动资产处置损失----------
四、利润总额561,509.85423,187.18225,598.14568,471.97501,325.13
减:所得税费用82,592.8558,727.1932,847.0291,764.7368,355.08
五、净利润478,917.01364,460.00192,751.12476,707.24432,970.05
归属于母公司所有者的净利润477,711.97363,291.13193,463.96474,941.55432,672.81
少数股东损益1,205.041,168.87-712.841,765.69297.24
六、每股收益
基本每股收益(元/股)2.68002.04001.08002.66002.4200
稀释每股收益(元/股)2.68002.04001.08002.66002.4200
七、其他综合收益305.24461.31-12.25-1,344.13-507.93
八、综合收益总额479,222.25364,921.31192,738.87475,363.10432,462.12
归属于母公司所有者的综合收益总额477,890.81363,616.98193,466.81473,769.03432,181.21
归属于少数股东的综合收益总额1,331.441,304.33-727.941,594.07280.90
下载全部历史数据到excel中 返回页顶